These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 37215130)

  • 21. A disulfidptosis-related classification and risk signature identifies immunotherapy biomarkers and predicts prognosis in gastric cancer: An observational study.
    Chen R; Jiang L
    Medicine (Baltimore); 2024 May; 103(22):e38398. PubMed ID: 39259065
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of cuproptosis-related subtypes, construction of a prognosis model, and tumor microenvironment landscape in gastric cancer.
    Wang J; Qin D; Tao Z; Wang B; Xie Y; Wang Y; Li B; Cao J; Qiao X; Zhong S; Hu X
    Front Immunol; 2022; 13():1056932. PubMed ID: 36479114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunogenic cell death related mRNAs associated signature to predict immunotherapeutic response in osteosarcoma.
    Han S; Wang Q; Shen M; Zhang X; Wang J
    Heliyon; 2024 Mar; 10(6):e27630. PubMed ID: 38515694
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of an immunogenic cell death-related lncRNAs signature for prognostic risk assessment in gastric cancer.
    Li W; Ding F; Zhang J
    Transl Cancer Res; 2024 Aug; 13(8):4420-4440. PubMed ID: 39262480
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of Immune-Related Molecular Subtypes and a Prognostic Signature Correlating With the Response to Immunotherapy in Patients With Gastric Cancer.
    Wang G; Yang L; Wang Y; Hu R; Zhang K; Guo T; Chen B; Jiang X; Cui R
    Front Immunol; 2022; 13():939836. PubMed ID: 35898512
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Establishing a signature based on immunogenic cell death-related gene pairs to predict immunotherapy and survival outcomes of patients with hepatocellular carcinoma.
    Ma J; Kuang L; Zhao R
    Aging (Albany NY); 2022 Dec; 14(23):9699-9714. PubMed ID: 36516498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Machine learning-based construction of immunogenic cell death-related score for improving prognosis and response to immunotherapy in melanoma.
    Li G; Zhang H; Zhao J; Liu Q; Jiao J; Yang M; Wu C
    Aging (Albany NY); 2023 Apr; 15(7):2667-2688. PubMed ID: 37036471
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Immunogenic Cell Death-Related Classification Predicts Prognosis and Response to Immunotherapy in Head and Neck Squamous Cell Carcinoma.
    Wang X; Wu S; Liu F; Ke D; Wang X; Pan D; Xu W; Zhou L; He W
    Front Immunol; 2021; 12():781466. PubMed ID: 34868055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pan-cancer analyses of immunogenic cell death-derived gene signatures: Potential biomarkers for prognosis and immunotherapy.
    Han X; Song D; Cui Y; Shi Y; Gu X
    Cancer Rep (Hoboken); 2024 Apr; 7(4):e2073. PubMed ID: 38627900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of an immunogenic cell death prognostic signature for predicting clinical outcome and immune infiltration characterization in stomach adenocarcinoma.
    Liu Y; Zhang L; Lei X; Yin X; Liu S
    Aging (Albany NY); 2023 Oct; 15(20):11389-11411. PubMed ID: 37862109
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comprehensive Characterization of RNA Processing Factors in Gastric Cancer Identifies a Prognostic Signature for Predicting Clinical Outcomes and Therapeutic Responses.
    Lou S; Meng F; Yin X; Zhang Y; Han B; Xue Y
    Front Immunol; 2021; 12():719628. PubMed ID: 34413861
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel prognostic signature based on immunogenic cell death score predicts outcomes and response to transcatheter arterial chemoembolization and immunotherapy in hepatocellular carcinoma.
    Zhang Y; Yang J; Xie S; Chen H; Zhong J; Lin X; Yu Z; Xia J
    J Cancer Res Clin Oncol; 2023 Oct; 149(13):11411-11429. PubMed ID: 37382674
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
    Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
    Front Immunol; 2022; 13():947802. PubMed ID: 36405735
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Unraveling the immunogenic cell death pathways in gastric adenocarcinoma: A multi-omics study.
    Gu R; Chen Z; Dong M; Li Z; Wang M; Liu H; Shen X; Huang Y; Feng J; Mei K
    Environ Toxicol; 2024 Oct; 39(10):4712-4728. PubMed ID: 38717048
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combining single-cell sequencing data to construct a prognostic signature to predict survival, immune microenvironment, and immunotherapy response in gastric cancer patients.
    Hu B; Meng Y; Qu C; Wang BY; Xiu DR
    Front Immunol; 2022; 13():1018413. PubMed ID: 36300104
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An immunogenic cell death-related classification predicts response to immunotherapy and prognosis in triple-negative breast cancer.
    Cheng XY; Liang Y; Zhang HF; Qian FZ; Sun XH; Liu XA
    Am J Transl Res; 2023; 15(4):2598-2609. PubMed ID: 37193173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunogenic cell death-based prognostic model for predicting the response to immunotherapy and common therapy in lung adenocarcinoma.
    Zhou X; Xu R; Lu T; Wang C; Chang X; Peng B; Shen Z; Yao L; Wang K; Xu C; Shi J; Zhang R; Zhao J; Zhang L
    Sci Rep; 2023 Aug; 13(1):13305. PubMed ID: 37587188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of Immunogenic Cell Death-Related Prognostic Gene Signature in Cervical Cancer Prognosis and Anti-Tumor Immunity.
    Jiang S; Cui Z; Zheng J; Wu Q; Yu H; You Y; Zheng C; Sun Y
    J Inflamm Res; 2023; 16():2189-2207. PubMed ID: 37250106
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenic cell death-related classifications guide prognosis and immunotherapy in osteosarcoma.
    Zong Y; Cao Y; Zhang D; Guan X; Zhang F; Shen Z; Yin F
    Sci Rep; 2023 Jun; 13(1):9118. PubMed ID: 37277499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An immunogenic cell death-related gene expression signature in predicting prognosis of pancreatic ductal adenocarcinoma.
    Wang X; Ren T; Liao C; Xie Y; Cao J
    BMC Genomics; 2024 Feb; 25(1):205. PubMed ID: 38395786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.